biosimilars in pharmacy practice: trastuzumab, rituximab and beyond
Published 4 years ago • 62 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:28
the role of pharmacists when introducing biosimilar monoclonal antibodies into practice
-
0:59
audit of rapid infusion of biosimilar rituximab
-
38:15
biosimilars and biologics
-
0:46
jeffrey patton, md: adopting biosimilar trastuzumab, bevacizumab, and rituximab in the clinic
-
3:38
biosimilar trastuzumab
-
1:41
dr. pegram on the development of trastuzumab biosimilars
-
33:12
biosimilar therapy 101
-
3:57
introduction of the biosimilar trastuzumab and its impact on patients and services
-
1:21
explaining biosimilars to our patients
-
1:47
the use of trastuzumab and biosimilars in the treatment of breast cancer
-
4:04
looking into the rich biosimilar landscape with cate lockhart of bbcic
-
11:15
pricing of biosimilars with biologics and other biosimilars
-
1:24
biosimilars: from science to practice in cancer care course overview
-
3:39
biosimilars for her2-targeted antibodies
-
6:43
biosimilars
-
1:05
key misconceptions about biosimilars
-
1:23
dr. rule on rituximab biosimilar use in the uk